- Projects & figures
- News & Events
- Managing your project
- About ERC
Microwaves are widely employed in the technologies we use in our daily life - from global navigation systems (like GPS or Galileo), to the satellites used for the weather forecast. They are also important for more ambitious endeavors such as space navigation. The work of Prof. Yanne Chembo has contributed to the next generation of microwaves.
To this day, little is known about sudden unexpected death in epilepsy. Only very few cases have actually been witnessed or monitored. But that might be about to change. Wearable electronics could provide just the solution researchers have been looking for.
Every day thousands of people across Europe are working together to keep EU citizens safe from challenges to do with health, the environment, crime, terrorism, migration and the economy.
Alina Badescu is a young researcher, with her head in the sky and her thoughts firmly buried under layers of rock – in some of her native Romania’s most stunning salt mines. Her work focuses on neutrinos, small subatomic particles that can tell us a lot about the phenomena in the universe: the birth of stars, the explosion of supernovas, black holes.
Tamoxifen, a drug used in breast cancer treatment, may be repositioned to treat pancreatic cancer
Pancreatic cancer is the 4th leading cause of death by cancer in Europe. It has a very low survival rate with less than 1 per cent of sufferers surviving for 10 or more years. Over the last 40 years the survival rate has not significantly changed and finding an effective therapy has become a pressing challenge in cancer research. A team based at Imperial College London led by Armando Del Río Hernández, has now demonstrated that a well-known drug could be effective to fight this deadly and other forms of cancer, such as liver cancer.
A project funded by the ERC developed an innovative and comprehensive framework to study energy poverty in Europe. It also produced evidence applicable beyond academia, laying ground for the EU’s Energy Poverty Observatory set up in 2018.
Cities and regions around the world are increasingly inter-connected. One clear factor for this connectivity is foreign investment: the flow of capital, skills and knowledge that can – under the right circumstances - "bless" an area, improving its economic and social standing. ERC grantee Riccardo Crescenzi studies where these flows are concentrated, how different actors choose where to invest and what are their impacts on both the home and host economies.
ERC grantee Dr Kazuya Koyama, originally from Japan, tests gravity, specifically whether Albert Einstein’s general theory of relativity can be applied beyond our solar system. At present general relativity works in our galaxy but is less convincing at the far borders of our universe which is rapidly expanding and needs weird energy to explain this. Dr Koyama is hoping that observations in deep space will show that the theory can be modified to work on a larger scale so that this strange 'dark energy' is not needed – removing one of cosmology's biggest mysteries.
On the occasion of the signing of a new agreement with the Japanese Science and Technology Agency to encourage top Japanese researchers to temporarily join ERC-funded teams in Europe, the ERC interviewed Dr Kazuya Koyama about his international career and how he believes this helps strengthen scientific partnerships between researchers in Europe and Japan.
Teaching is certainly one of the most important professions in our society, yet its status and attractiveness have been systematically diminishing in the last decades. At the Université catholique de Louvain, Prof. Xavier Dumay is using his ERC Starting Grant to investigate the cultural and institutional transformations that have led to this "teaching profession crisis".
CRISPR is a widely used molecular biology tool exploiting an immune process discovered in bacteria. Dr David Bikard studies CRISPR in bacterial cells, in conjunction with different DNA repair systems, to create even newer tools. He hopes to gain insight into bacterial genetics, and develop increasingly effective medical treatments.